Violation Tracker Individual Record
Company:
Actelion Pharmaceuticals US, Inc.
Current Parent Company:
Johnson & Johnson
Penalty:
$360,000,000
Year:
2018
Date:
December 6, 2018
Offense Group:
government-contracting-related offenses
Primary Offense:
False Claims Act and related
Secondary Offense:
kickbacks and bribery
Violation Description:
Pharmaceutical company Actelion Pharmaceuticals US, Inc. agreed to pay $360 million to resolve claims that it illegally used a foundation as a conduit to pay the copays of thousands of Medicare patients taking Actelion's pulmonary arterial hypertension drugs, in violation of the False Claims Act.
Level of Government:
federal
Action Type:
agency action
Agency:
Justice Department Civil Division
Civil or Criminal Case:
civil
HQ Country of Parent:
USA
HQ State of Parent:
New Jersey
Ownership Structure of Parent:
publicly traded
Major Industry of Parent:
pharmaceuticals
Specific Industry of Parent:
pharmaceuticals
Source of Data:
https://www.justice.gov/opa/pr/drug-maker-actelion-agrees-pay-360-million-resolve-false-claims-act-liability-paying
Source Notes:
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note:
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.
